CytoSorbents granted inducement equity awards to new CFO Peter J. Mariani.

From GlobeNewswire: 2024-08-16 16:05:00

CytoSorbents Corporation granted inducement equity awards to its new Chief Financial Officer, Peter J. Mariani on August 14, 2024. The awards include stock options to purchase 215,000 shares of common stock, restricted stock units for 65,000 shares, and additional RSUs totaling 285,000 shares. The options have an exercise price of $0.90 per share. CytoSorbents is a leader in blood purification technologies, with their product CytoSorb® approved in the EU and used in 76 countries worldwide. The company’s technologies have received funding from various government agencies and they have numerous products based on their unique blood purification technology.



Read more at GlobeNewswire: CytoSorbents Announces Inducement Grants Under Nasdaq